Oxamflatin Improves Development of Bovine Cloned Embryos
Author Information
Author(s): Su Jianmin, Wang Yongsheng, Li Yanyan, Li Ruizhe, Li Qian, Wu Yongyan, Quan Fusheng, Liu Jun, Guo Zekun, Zhang Yong
Primary Institution: College of Veterinary Medicine, Northwest A&F University
Hypothesis
Can Oxamflatin enhance the nuclear reprogramming and development of bovine SCNT embryos in vitro?
Conclusion
Oxamflatin treatment enhances the quality and developmental potential of bovine SCNT embryos by modifying epigenetic status and gene expression.
Supporting Evidence
- Oxamflatin treatment increased the total and inner cell mass cell numbers in SCNT blastocysts.
- The ratio of inner cell mass to trophectoderm cells was significantly higher in Oxamflatin-treated embryos.
- Oxamflatin reduced the rate of apoptosis in SCNT blastocysts.
- Histone acetylation levels were increased in SCNT embryos treated with Oxamflatin.
- Oxamflatin treatment led to lower DNA methylation levels in the satellite I region of SCNT blastocysts.
Takeaway
Oxamflatin is a special medicine that helps cloned cow embryos grow better by changing how their genes work.
Methodology
The study involved treating bovine SCNT embryos with different concentrations of Oxamflatin and assessing their development through various stages.
Limitations
The study primarily focused on in vitro conditions, which may not fully replicate in vivo environments.
Participant Demographics
Bovine embryos derived from a newborn female Holstein calf.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website